Mar 7, 2016 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
Patent filing describes a device that is intended to allow patients to collect their own blood specimens without the need for needles
Google, (now known as Alphabet, Inc.; NASDAQ:GOOG) recently filed an application for another patent that deals with medical laboratory test technology. This patent application is for a needle-free blood draw system that enables patients to perform diagnostic testing on themselves.
The new system is designed to replace painful finger pricks and deliver diagnostic test results digitally to providers’ electronic health record (EHR) systems. Should the technology make it through clinical trials, widespread adoption of such a device could have sweeping implications for pathologists and clinical laboratories across America. (more…)
Feb 4, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Concept is for patients to take a pill containing nanoparticles programmed to detect cancers or other disease symptoms and a wearable gadget would report their findings
Google is using the same biomarker molecules as clinical laboratories in an attempt to enable in vitro monitoring of an individual’s health status. The device is under development and represents yet one more effort by Google (NASDAQ:GOOG) to penetrate the market for consumer health services.
This futuristic project is under development by the Google X Life Sciences team. The goal is create a device that would allow patients to noninvasively self-diagnose most diseases and health conditions.
The team is led by Andrew Conrad Ph.D.. The device under development is called the NanoParticle platform. It is a tool that continuously monitors an individual’s health status from the inside and reports what it finds through a wearable, watch-like device. (more…)
Oct 8, 2014 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Google’s goal is to build a genomics database to facilitate early diagnosis and prevention of life-threatening diseases; may give pathologists a new diagnostic tool
Google (NASDAQ: GOOG) is preparing to build a human genome database that it says may become the world’s biggest. The company plans to also assemble other medical information, including clinical laboratory test data, as it pursues plans to become a player in the market for healthcare Big Data.
This work will be done by Google X Life Sciences, a new business for Google. The project is known as the Baseline Study. (more…)
May 9, 2014 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Big Data will play major role as Venter’s team sets out to build world’s largest database of human genotypes, microbiomes and phenotypes
For the second time in recent months, another prominent figure has declared his intention to crack the code of human aging. This time it is scientist and entrepreneur J. Craig Venter, Ph.D., known for his role in sequencing the first whole human genome.
Venter will pursue this goal through a brand new company he launched, called Human Longevity, Inc. (HLI), based in La Jolla, California.
Human Longevity, Inc. Will Compete Against Calico
This is a noteworthy development. Pathologists and clinical laboratory managers already know Venter’s competition in this race is a company called Calico that was founded by several entrepreneurs linked to Google. (more…)
Mar 26, 2014 | Digital Pathology, Instruments & Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology
If successful, the knowledge gained from this research may provide new tools and medical laboratory tests that pathologists can use in the management of geriatric patients
Google’s founders believe that analysis of the genomes of people who live to be 100 years old and are relatively healthy will allow them to solve the puzzle of human aging. They have funded a new company specifically to pursue this goal.
In the near future, it is unlikely that any of the science developed by this venture will lead to a diagnostic profile or clinical laboratory tests that pathologists can use to help clinicians who deal with the diseases associated with aging. But should the research team at Calico develop a better understanding of the dynamics of human aging, it would certainly be expected that this knowledge would be used to develop appropriate medical laboratory tests. (more…)
